Ferumoxytol

Grey

Brand Name(s):Rienso

Indication:Iron deficiency anaemia in adult patients with chronic kidney disease

Rationale:3

Considered:May-12

Review Date:Apr-20

Comments:
MHRA – DRUG SAFETY UPDATE
Summary
New recommendations are being introduced to minimise the risk of serious hypersensitivity reactions with ferumoxytol. These include a contraindication in patients with any drug allergies and changes in the method of administration
Further info at:http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON452538
Sept 2014